As of June 2026 Regeneron Pharmaceuticals has a market cap of A$96.14 Billion. This makes Regeneron Pharmaceuticals the world's 376th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jun 27th, 2026 the market cap of Regeneron Pharmaceuticals was reported to be: